Leaky gut in chronic fatigue syndrome: A review

Activitas Nervosa Superior Rediviva

Volumn 51, Issue 1-2, 2009, Pages 21-28

  Maes, Michael ^a  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

Author keywords

Bacterial translocation; Chronic fatigue syndrome; Cytokines; Endotoxin; Enterobacteria; Gut permeability; Iga; Inflammation; Leaky gut; Lps; Oxidative stress

Indexed keywords

EID: 84865173265     PISSN: 1337933X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. JA, Poiurovskii MV, Neznamov GG, Seredeniia SB, Krasova EA (1988). Lipid peroxidation in emotional stress and neurotic disorders. Zh Nevropatol Psikhiatr Im S S Korsakova. 88(11): 95-101.
2. Al-Sadi RM & Ma TY (2007). IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 178(7): 4641-4649.
3. Ann JY, Kim SJ, Han SP, Kim JW, Kim HJ, Do JH et al (2004). Effect of glutamine on the non-steroidal anti-inflammatory druginduced bacterial translocation. Korean J Gastroenterol. 44(5): 252-258.
4. Aoki T, Miyakoshi H, Usuda Y, Herberman RB (1993). Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol. 69: 253-265.
5. Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA (1994). Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 18(Suppl.1): S136-141.
6. Bellmann-Weiler R, Schroecksnadel K, Holzer C, Larcher C, Fuchs D, Weiss G (2008). IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection. J Affect Disord. 108(1-2): 171-176.
7. Beqaj SH, Lerner AM, Fitzgerald JT (2008). Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol. 61(5): 623-626.
8. Berg RD (1992). Bacterial translocation from the gastrointestinal tract. J Med. 23: 217-244.
9. Bjarnason I, Peters TJ, Wise RJ (1984). The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1(8370): 179-82.
10. Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ (1986). Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 27(11): 1292-1297.
11. Borowski T, Kokkinidis L, Merali Z, Anisman H (1998). Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport. 9(17): 3797-3802.
12. Brasier AR (2006). The NF-kappaB regulatory network. Cardiovasc Toxicol. 6: 111-130.
13. Brown GC (1999). Nitric oxide and mitochondrial respiration. Biochim Biophys Acta. 1411: 351-369.
14. Buchman AL (1999). Glutamine for the gut: mystical properties or an ordinary amino acid? Curr Gastroenterol Rep. 1(5): 417-423.
15. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment
16. Cameron HL, Perdue MH (2005). Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther. 314(1):214-220.
17. Chavez AM, Menconi MJ, Hodin RA, Fink MP (1999). Cytokineinduced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 27(10): 2246-2251.
18. Chen P, Soares AM, Lima AA, Gamble MV, Schorling JB, Conway M et al (2003). Association of vitamin A and zinc status with altered intestinal permeability: analyses of cohort data from northeastern Brazil. J Health Popul Nutr. 21(4): 309-315.
19. Chia JK & Chia AY (2008). Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 61(1): 43-48.
20. Clark EC, Patel SD, Chadwick PR, Warhurst G, Curry A, Carlson GL (2003). Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut. 52(2): 224-230.
21. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G (2005). Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology. 128(5):1258-1267.
22. Coltart RS, Howard GC, Wraight EP, Bleehen NM (1988). The effect of hyperthermia and radiation on small bowel permeability using 51 Cr EDTA and 14C mannitol in man. Int J Hyperthemia. 4: 467-477.
23. Davis MS, Willard MD, Williamson KK, Steiner JM, Williams DA (2005). Sustained strenuous exercise increases intestinal permeability in racing Alaskan sled dogs. J Vet Intern Med. 19(1): 34-39.
24. Di Leo V, D'Incà R, Barollo M, Tropea A, Fries W, Mazzon E et al (2001). Effect of zinc supplementation on trace elements and intestinal metallothionein concentrations in experimental colitis in the rat. Dig Liver Dis. 33(2): 135-139.
25. Dowsett EG, Ramsay AM, McCartney RA, Bell EJ (1990). Myalgic encephalomyelitis - a persistent enteroviral infection? Postgrad Med J. 66(777): 526-530.
26. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB (1995). Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 95(4): 1669-1675.
27. Foitzik T, Stufler M, Hotz HG, Klinnert J, Wagner J, Warshaw AL et al (1997). Glutamine stabilizes intestinal permeability and reduces pancreatic infection in acute experimental pancreatitis. J Gastrointest Surg. 1(1): 40-46; discussion 46-7.
28. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Int Med. 121(12): 953-959.
29. Garcia JM, Espanol T, Gurbindo MD, Casas CC (2007). Update on the treatment of primary immunodeficiencies. Allergol Immunopathol (Madr). 35(5): 184-192.
30. Gerrity TR, Papanicolaou DA, Amsterdam JD, Bingham S, Grossman A, Hedrick T et al (2004). CFIDS Association of America. Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation. 11: 351-357.
31. Herek O, Ozturkk H, Ozyurt M, Albay A, Cetinkursun S (2000). Effects of treatment with immunoglobulin on bacterial translocation in burn wound infection. Ann Burns Fire Disasters. XIII(1): 1-7.
32. Irie M, Asami S, Nagata S, Miyata M, Kasai H (2001). Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health. 74(2): 153-157.
33. Katafuchi T, Kondo T, Take S, Yoshimura M (2005). Enhanced expression of brain interferon-alpha and serotonin transporter in immunologically induced fatigue in rats. Eur J Neurosci. 22(11): 2817-2826.
34. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ (2005). Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biol Med. 39(5): 584-589.
35. Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI et al (2008). Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis. 197(8): 1171-1184.
36. Klapcinska B, Kempa K, Sobczak A, Sadowska-Krepa E, Jagsz S, Szoltysek I (2005). Evaluation of autoantibodies against oxidized LDL (oLAB) and blood antioxidant status in professional soccer players. Int J Sports Med. 26(1): 71-78.
37. Klimas N, Salvato F, Morgan R, Fletcher MA (1990). Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 28: 1403-1410.
38. Kramer HF & Goodyear LJ (2007). Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. J Appl Physiol. 103(1): 388-395.
39. Lacosta S, Merali Z, Anisman H (1999). Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818(2): 291-303.
40. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2004). IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo. 18(2): 101-106.
41. Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2007). Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. In Vivo. 21(5): 707-713.
42. Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE (1993). Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol. 28(7): 573-580.
43. Linde A, Anderson B, Svenson SB, Ahrne H, Carlsson M, Forsberg P et al (1992). Serum level of lymphokines and soluble cellular receptors in primar EBV infection and in patients with chronic fatigue syndrome. J Infect Dis. 165: 994-1000.
44. Lipton SA (1996). Neuronal protection and destruction by NO. Cell Death Differ. 6: 943-951.
45. Lloyd A, Hickie I, Hickie C, Dwyer J, Wakefield D (1992). Cellmediated immunity in patients with chronic fatigue syndrome, healthy controls and patients with major depression. Clin Exp Immunol. 87: 76-79.
46. Ma TY, Boivin MA, Ye D, Pedram A, Said HM (2005). Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 288(3): G422-430.
47. Maes M, Meltzer HY, Scharpé S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C et al (1993). Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res. 47(3): 229-241.
48. Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G et al (1998). The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 10(4): 313-318.
49. Maes M, Mihaylova I, De Ruyter M (2005). Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS. Neuro Endocrinol Lett. 26(5): 487-492.
50. Maes M, Mihaylova I, De Ruyter M (2006a). Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord. 90(2-3): 141-147.
51. Maes M, Mihaylova I, Leunis JC (2006b). Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett. 27(5): 615-621.
52. Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E (2007a). The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett. 28(6): 826-831.
53. Maes M, Mihaylova I, Leunis JC (2007b). Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 28(6): 861-867.
54. Maes M, Mihaylova I, Bosmans E (2007c). Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro Endocrinol Lett. 28(4): 456-462.
55. Maes M, Mihaylova I, Kubera M, Bosmans E (2007d). Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro Endocrinol Lett. 28(4): 463-469.
56. Maes M, Mihaylova I, Leunis JC (2007e). Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord. 99(1-3): 237-240.
57. Maes M, Coucke F, Leunis JC (2007f ). Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett. 28(6): 739-744.
58. Maes M & Leunis JC (2008). Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical remission in CFS: effects of age, duration of illness and increased IgA responses against translocated LPS of gram-negative bacteria. Neuro Endocrinol Lett. 29(6):902-910.
59. Maes M, Mihaylova I, Kubera M, Leunis JC (2008). An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Neuro Endocrinol Lett. 29(3): 313-9.
60. Maes M (2009). Inflammatory and oxidative & nitrosative stress (IO&NS) pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opinion Psychiatry. 22(1): 75-83.
61. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G et al (2009). The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 24(1): 27-53.
62. Makata H, Ichiyama T, Uchi R, Takekawa T, Matsubara T, Furukawa S (2006). Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease. Naunyn Schmiedebergs Arch Pharmacol. 373(5): 325-332.
63. Martin KA, Krahn LE, Balan V, Rosati MJ (2007). Modafinil's use in combating interferon-induced fatigue. Dig Dis Sci. 52(4): 893-896.
64. Meddings JB, Swain MG (2000). Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology. 119(4): 1019-1028.
65. Menezes MC, Benard G, Sato MN, Hong MA, Duarte AJ (1997). In vitro inhibitory activity of tumor necrosis factor alpha and interleukin-2 of human immunoglobulin preparations. Int Arch Allergy Immunol. 114(4): 323-328.
66. Mihaylova I, DeRuyter M, Rummens JL, Bosmans E, Maes M (2007). Deceased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett. 2007; 28(4): 477-83.
67. Lepsch LB, Kawamoto EM, Malta MB, Lima Lde S, Avellar MC et al (2006). Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci. 26(14): 3813-3820.
68. Ohmori H & Kanayama N (2005). Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev. 4(4): 224-9.
69. Olanders K, Borjesson A, Sun ZW, Andersson R (2003). Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. Scand J Gastroenterol. 38(6): 618-625.
70. Orhan H, van Holland B, Krab B, Moeken J, Vermeulen NP, Hollander P et al (2004). Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise. Free Radic Res. 38(12): 1269-1279.
71. Pape HC, Dwenger A, Regel G, Auf'm'Kolck M, Gollub F, Wisner D et al (1994). Increased gut permeability after multiple trauma. Br J Surg. 81(6): 850-852.
72. Patarca R, Lugtendorf S, Antony M, Klimas NG, Fletcher MA (1994). Dysregulated expression of tumor necrosis factor in the chronic fatigue immune dysfunction syndrome: Interrelations with cellular sorces and patterns of soluble immune mediator expression. Clin Infect Diseases. 18: 147-153.
73. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB (1995): Prevalence of IgM antibodies to human herpesvirus early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis. 172(5): 1364-1367.
74. Pertsov SS, Balashova TS, Kubatieva AA, Sosnovskii AS, Pirogova GV, Abramov VM (1995). [Lipid peroxidation and antioxidant enzymes in rat brain in acute emotional stress: effect of interleukin-1beta]. Biull Eksp Biol Med. 120(9): 244-247.
75. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS et al (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 55(5): 453-462.
76. Quan ZF, Yang C, Li N, Li JS (2004). Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol. 10(13): 1992-1994.
77. Richards RS, Wang L, Jelinek H (2007). Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res. 38(1): 94-98.
78. Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T et al (1996). Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA. 275(13): 1007-1012.
79. Rossi F & Kazatchkine MD (1989). Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol. 143(12): 4104-4109.
80. Seishima M, Mizutani Y, Shibuya Y, Arakawa C (2008). Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia. Dermatology. 216(4): 341-346.
81. Shanahan F (1994). Current concepts of the pathogenesis of inflammatory bowel disease. Ir J Med Sci. 163: 544-549.
82. Singh A, Garg V, Gupta S, Kulkarni SK (2002a). Role of antioxidants in chronic fatigue syndrome in mice. Ind J Exp Biol. 40(11): 1240-1244.
83. Singh A, Naidu PS, Gupta S, Kulkarni SK (2002b). Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food. 5(4): 211-220.
84. Sivonova M, Zitnanova I, Hlincikova L, Skodacek I, Trebaticka J, Durackova Z (2004). Oxidative stress in university students during examinations. Stress. 7(3): 183-188.
85. Skansen-Saphir U, Andersson J, Bjork L, Ekberg C, Fehniger TE, Henter JI et al (1998). Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells. Scand J Immunol. 47(3): 229-235.
86. Smirnova IV & Pall ML (2003). Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol Cell Biochemistry. 248(1-2): 93-95.
87. Sturniolo GC, Di Leo V, Ferronato A, D'Odorico A, D'Inca R (2001). Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis. 7(2): 94-98.
88. Sun Z, Lasson A, Olanders K, Deng X, Andersson R (2002). Gut barrier permeability, reticuloendothelial system function and protease inhibitor levels following intestinal ischaemia and reperfusion-effects of pretreatment with N-acetyl-L-cysteine and indomethacin. Dig Liver Dis. 34(8): 560-569.
89. Sundqvist T, Lindstrom F, Magnusson KE, Sköldstam L, Stjernström I, Tagesson C (1982). Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis. Scand J Rheumatol. 11(1): 33-38.
90. Tran CD, Butler RN, Howarth GS, Philcox JC, Rofe AM, Coyle P (1999). Regional distribution and localization of zinc and metallothionein in the intestine of rats fed diets differing in zinc content. Scand J Gastroenterol. 34(7): 689-695.
91. Tran CD, Howarth GS, Coyle P, Philcox JC, Rofe AM, Butler RN (2003). Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine. Am J Clin Nutr. 77(5): 1296-1303.
92. Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T et al (2003). Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 335(3): 151-154.
93. Viljoen M, Panzer A, Willemse N (2003). Gastro intestinal hyperpermeability: a review. East Afr Med J. 80(6): 324-330.
94. Visser J, Blauw B, Hinloopen B, Broomer E, de Kloet ER, Kluft C, Nagelkerken L (1998). CD4 lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis. 177: 451-454.
95. Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M (2005). Early increase in vegetative symptoms predicts IFN-alphainduced cognitive-depressive changes. Psychol Med. 35(3): 433-441.
96. Wischmeyer PE (2006). Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care. 9(5): 607-612.
97. Wu GH, Wang H, Zhang YW, Wu ZH, Wu ZG (2004). Glutamine supplemented parenteral nutrition prevents intestinal ischemia- reperfusion injury in rats. World J Gastroenterol. 10(17): 2592-2594.
98. Wu KH, Wu WM, Lu MY, Chiang BL (2006). Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells. Pediatr Allergy Immunol. 17(1): 60-68.
99. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL et al (2003). IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol. 285(3): G621-629.
100. Ye D, Ma I, Ma TY (2006). Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 290(3): G496-504.
101. Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D (2003). The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. J Parenter Enter Nutr. 27(4): 241-245.